A carregar...
Open‐label, proof‐of‐concept study of brexanolone in the treatment of severe postpartum depression
OBJECTIVE: Preclinical evidence indicates that rapid changes in levels of allopregnanolone, the predominant metabolite of progesterone, confer dramatic behavioral changes and may trigger postpartum depression (PPD) in some women. Considering the pathophysiology of PPD (i.e., triggered by reproductiv...
Na minha lista:
| Publicado no: | Hum Psychopharmacol |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5396368/ https://ncbi.nlm.nih.gov/pubmed/28370307 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hup.2576 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|